help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emler, S.
Right arrow Articles by Hirschel, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emler, S.
Right arrow Articles by Hirschel, B.

Am. J. Respir. Crit. Care Med., Vol 150, No. 1, 07 1994, 261-265.

Chronic destructive lung disease associated with a novel mycobacterium

S Emler, T Rochat, P Rohner, C Perrot, R Auckenthaler, L Perrin and B Hirschel
Division of Infectious Diseases, Hopital Cantonal Universitaire, Geneva, Switzerland.

A woman born in 1920 has suffered from a chronic destructive lung disease since 1972, with development of a severe combined restrictive and obstructive ventilatory defect. Large quantities of acid-fast microorganisms have been repeatedly observed in her sputum. Multiple courses of antimycobacterial treatment did not stop the progression of the disease. The mycobacterium involved was first identified as Mycobacterium gordonae, and later as Mycobacterium scrofulaceum. Analysis of part of the amplified gene of the 16S rRNA, however, revealed that its sequence differed from that of any established mycobacterial species, although it was observed once before in a German lymph node isolate, for which the name "Mycobacterium interjectum" has been proposed. Retrospective analysis confirmed the presence of this sequence in frozen samples which had been provided by the patient in 1983, 1985, 1989, 1990, and 1993. Our case confirms the value of amplification and sequencing of mycobacterial 16S rRNA for classifying mycobacteria, and suggests that "Mycobacterium interjectum" may be involved in cases of chronic destructive lung disease.


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
E. Tortoli
Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s
Clin. Microbiol. Rev., April 1, 2003; 16(2): 319 - 354.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
T. De Baere, M. Moerman, L. Rigouts, C. Dhooge, H. Vermeersch, G. Verschraegen, and M. Vaneechoutte
Mycobacterium interjectum as Causative Agent of Cervical Lymphadenitis
J. Clin. Microbiol., February 1, 2001; 39(2): 725 - 727.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1994 American Thoracic Society